Evidence map›Paper›PMID 39429784›Full record

ArticleiScience2024

Behenic acid alleviates inflammation and insulin resistance in gestational diabetes mellitus by regulating TLR4/NF-κB signaling pathway.

Kerong Liu, Ying Gu, Xingnan Pan, Sha Chen, Jie Cheng, Le Zhang, Minkai Cao

Abstract read
In one paragraph

Article in iScience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. The protective effect ofFrontiers in microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kerong LiuDepartment of Endocrinology, Affiliated Children's Hospital of Jiangnan University (Wuxi Children's Hospital), Wuxi 214023, Jiangsu, China.
Ying GuDepartment of Obstetrics and Gynecology, Affiliated Women's Hospital of Jiangnan University (Wuxi Maternity and Child Health Care Hospital), Wuxi 214002, Jiangsu, China.
Xingnan PanDepartment of Pediatric, Affiliated Children's Hospital of Jiangnan University (Wuxi Children's Hospital), Wuxi 214023, Jiangsu, China.
Sha ChenDepartment of Obstetrics and Gynecology, Affiliated Women's Hospital of Jiangnan University (Wuxi Maternity and Child Health Care Hospital), Wuxi 214002, Jiangsu, China.
Jie ChengCenter for Reproductive Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200135, China.
Le ZhangDepartment of Neonatology, Affiliated Children's Hospital of Jiangnan University (Wuxi Children's Hospital), Wuxi 214023, Jiangsu, China.
Minkai CaoDepartment of Obstetrics and Gynecology, Affiliated Women's Hospital of Jiangnan University (Wuxi Maternity and Child Health Care Hospital), Wuxi 214002, Jiangsu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gestational diabetes mellitus (GDM) is a distinct form of diabetes that poses a significant threat to the health of both pregnant women and fetuses. The objective of this study was to investigate the impact of behenic acid (BA) on glucose metabolism, inflammation, and insulin resistance in GDM mice, and to elucidate the underlying molecular mechanism. Here, we demonstrated that daily administration of 10 mg/mL BA during pregnancy effectively ameliorated abnormal glucose metabolism in GDM mice and their offspring and improved birth outcomes in the offspring. Moreover, BA promoted the proliferation of islet β cells, restored their normal function, and augmented glucose uptake by skeletal muscle cells. Mechanistically, BA mitigated inflammation and insulin resistance in GDM mice by inhibiting activation of the TLR4/NF-κB signaling pathway. Our study provides compelling evidence supporting the efficacy of BA in improving GDM, suggesting its potential use as a dietary supplement for preventing and treating GDM.

Indexed as

Endocrinology of pregnancyLaboratory endocrinologyMolecular biology

Identifiers

PMID39429784
PMCPMC11490720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.